<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83637">
  <stage>Registered</stage>
  <submitdate>24/02/2009</submitdate>
  <approvaldate>17/04/2009</approvaldate>
  <actrnumber>ACTRN12609000183280</actrnumber>
  <trial_identification>
    <studytitle>The influence of differing inspired oxygen concentrations on platelet function in a model of ischaemic reperfusion injury</studytitle>
    <scientifictitle>A trial of patients with an upper limb arterial tournique and whether an increase in inspired oxygen concentration at the time of reperfusion has any effect on platelet activation, as assessed by flow cytometry and thromboelastography</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Ischaemic reperfusion injuries</healthcondition>
    <conditioncode>
      <conditioncode1>Blood</conditioncode1>
      <conditioncode2>Clotting disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Increasing the fractional inspired oxygen concentration to 0.5 and 0.8 from 0.3 at the time of reperfusion. This is achieved by altering oxygen concentration on the ventilator. This is a one off treatment started 10 minutes before tourniquet release and continued until 30 minutes after tourniquet release.</interventions>
    <comparator>Keeping the fractional inspired oxygen concentration at 0.3 at the time of reperfusion. This is a one off treatment started 10 minutes before tourniquet release and continued until 30 minutes after tourniquet release.</comparator>
    <control>Dose comparison</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change in platelet activation as assessed by flow cytometry (degree of change unknown)</outcome>
      <timepoint>pre induction, 10 mins pre tourniquet deflation, immediately pre tourniquet deflation, 5 mins post tourniquet and 30 mins post tourniquet deflation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Change in platelet activation as assessed by thromboelastography (degree of change unknown)</outcome>
      <timepoint>pre induction, 10 mins pre tourniquet deflation, immediately pre tourniquet deflation, 5 mins post tourniquet and 30 mins post tourniquet deflation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1. Adult patients undergoing upper limb surgery that requires the use of a tourniquet for more than 45 minutes
2. American Society of Anaesthesiology (ASA) grade 1 or 2</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. Patients taking any antiplatelet medication
2. Confirmed coagulation disorder (pathological or drug induced)
3. Platelet count less then 80 x 109/l
4. Blood urea greater than 8.0 mmol/L
5. Systemic infection 
6. Confirmed systemic Inflammatory diseases
7. Documented pregnancy
8. Documented malignancy
9. Trauma other than the ipsilateral upper limb
10. Multiple tourniquet episodes
11. Likely intraoperative O2 requirement &gt; 30%</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Identified from theatre lists. Written informed consent as per ethical guidelines. Allocation concealment by sealed opaque envelopes. Patients blinded to intervention.</concealment>
    <sequence>Random number generator using computerised sequence generation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>23/03/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>45</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Royal Perth Hospital</primarysponsorname>
    <primarysponsoraddress>Royal Perth Hospital,
Wellington street Campus,
Perth 6000
WA</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Royal Perth Hospital Medical Research Fundation</fundingname>
      <fundingaddress>Royal Perth Hospital,
Wellington street Campus,
Perth 6000
WA</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Perth Ethics Committee</ethicname>
      <ethicaddress>Royal Perth Hospital,
Wellington street Campus,
Perth 6000
WA</ethicaddress>
      <ethicapprovaldate>5/12/2008</ethicapprovaldate>
      <hrec>EC 2008/200</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Thomas Collyer</name>
      <address>Department of anaesthesia
Royal Perth Hospital,
Wellington street Campus,
Perth 6000
WA</address>
      <phone>+61 (8) 93843517</phone>
      <fax />
      <email>tomcollyer@doctors.org.uk</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Thomas Collyer</name>
      <address>Department of anaesthesia
Royal Perth Hospital,
Wellington street Campus,
Perth 6000
WA</address>
      <phone>+61 (8) 93843517</phone>
      <fax />
      <email>tomcollyer@doctors.org.uk</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Thomas Collyer</name>
      <address>Department of anaesthesia
Royal Perth Hospital,
Wellington street Campus,
Perth 6000
WA</address>
      <phone>+61 (8) 93843517</phone>
      <fax />
      <email>tomcollyer@doctors.org.uk</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>